← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
151	ORTX 151 DELISTED Orchard Therapeutics plc American Depositary Shares ORTX	–	–	–	–
152	152 Passage Bio PASG $11.3M	–	–	–	–
153	153 PepGen PEPG $180M	–	–	–	–
154	154 PharmaCyte Biotech PMCB $3.65M	–	–	–	–
155	155 Prime Medicine PRME $629M	–	–	–	–
156	156 ProKidney PROK $278M	–	–	–	–
157	157 ProQR Therapeutics PRQR $185M	–	–	–	–
158	158 Personalis PSNL $1.67B	–	–	–	–
159	159 DELISTED Poseida Therapeutics, Inc. Common Stock PSTX	–	–	–	–
160	PTE 160 DELISTED PolarityTE, Inc. Common Stock PTE	–	–	–	–
161	161 Qiagen QGEN $9.53B	–	–	–	–
162	162 Quantum-Si Incorporated QSI $245M	–	–	–	–
163	163 uniQure QURE $1.51B	–	–	–	–
164	164 Ultragenyx Pharmaceutical RARE $1.43B	–	–	–	–
165	165 Rocket Pharmaceuticals RCKT $239M	–	–	–	–
166	RCOR 166 DELISTED Renovacor, Inc. RCOR	–	–	–	–
167	167 Regenxbio RGNX $457M	–	–	–	–
168	168 Atrium Therapeutics RNA $131M	–	–	–	–
169	169 Cartesian Therapeutics RNAC $190M	–	–	–	–
170	RUBY 170 DELISTED Rubius Therapeutics, Inc RUBY	–	–	–	–
171	171 Sana Biotechnology SANA $680M	–	–	–	–
172	SCPS 172 DELISTED Scopus BioPharma Inc. Common Stock SCPS	–	–	–	–
173	SCTX 173 Scribe Therapeutics Inc SCTX $380M	–	–	–	–
174	SGTX 174 DELISTED Sigilon Therapeutics, Inc. Common Stock SGTX	–	–	–	–
175	SIOX 175 DELISTED Sio Gene Therapies Inc. Common Stock SIOX	–	–	–	–